FDA Pushes Drugmakers to Develop Addiction Treatments

In response to a spike in addiction to cocaine, meth or prescription stimulants, often in combination with opioids, the Food and Drug Administration is calling on drugmakers to develop treatments for stimulant use disorder, Jason Millman reports for Axios. The agency recommended clinical trial sponsors separately study people who use cocaine, meth and prescription stimulants to improve the odds of developing successful treatments. There are currently no approved treatments to help address addiction to cocaine, meth or prescription stimulants.

Related Articles


Your email address will not be published. Required fields are marked *